Article
The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
11 Aug 2023
Abstract excerpt
We investigate the mechanism associated with the severity of COVID-19 in men with TLR7 mutation. Men with loss-of-function (LOF) mutations in TLR7 had severe COVID-19. LOF mutations in TLR7 increased the risk of critical COVID by 16.00-fold (95% confidence interval 2.40-106.73). The deleterious mutations affect the binding of SARS-CoV2 RNA (- 328.66 ± 26.03 vs. - 354.08 ± 27.70, p = 0.03) and MYD88 (β: 40.279, p...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
